Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
26.74
+0.01 (0.04%)
Feb 21, 2025, 4:00 PM EST - Market closed
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.77 billion as of February 21, 2025. Its market cap has decreased by -31.15% in one year.
Market Cap
1.77B
Enterprise Value
-1.48B
1-Year Change
-31.15%
Ranking
Category
Stock Price
$26.74
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has decreased from $1.86B to $1.77B, a decrease of -5.22%. That is a compound annual growth rate of -0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.76B | -2.76% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |